本页面由Tiger Trade Technology Pte. Ltd.提供服务

Viking Therapeutics, Inc.

35.51
+0.06000.17%
盘后35.550.0400+0.11%19:20 EDT
成交量:151.21万
成交额:5,349.49万
市值:41.03亿
市盈率:-11.12
高:35.67
开:35.45
低:34.85
收:35.45
52周最高:43.15
52周最低:21.23
股本:1.16亿
流通股本:1.10亿
量比:0.79
换手率:1.37%
股息:- -
股息率:- -
每股收益(TTM):-3.1920
每股收益(LYR):-3.1920
净资产收益率:-47.34%
总资产收益率:-30.27%
市净率:6.42
市盈率(LYR):-11.12

数据加载中...

2024/05/23

重要事件披露

Form 8-K - Current report
2024/05/23

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/22

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/22

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/25

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/24

重要事件披露

Form 8-K - Current report
2024/03/26

重要事件披露

Form 8-K - Current report
2024/03/04

重要事件披露

Form 8-K - Current report
2024/03/01

重要事件披露

Form 8-K - Current report
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/07

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/07

重要事件披露

Form 8-K - Current report